Skip to the page

Data / Form D filings / Elastro, Inc.

Elastro, Inc.: Form D filing

Elastro, Inc., a biotechnology company in Watertown, MA, filed a Form D with the SEC in 2025. The latest, on August 15, 2025, reports $2.3 million sold of a $2.3 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
94 UNION ST, Watertown, MA, 02472
Phone
(614) 507-9586
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2076219

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Aug 15, 2025New notice$2,325,000$2,325,0006May 30, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael SchraderExecutive Officer, Director
Ren Mark LiuDirector
Jia LiuDirector
Robert Mark RichardsonDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Aug 11, 2025 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Elastro, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.